$56.60
+1.88 (+3.44%)
At Close: Jun 04, 2026
Imbed Biosciences Appoints Bristol Myers Squibb Veteran Terry Bromley as Chief Executive Officer
08:30am, Thursday, 19'th Dec 2024
MIDDLETON, Wis.--(BUSINESS WIRE)-- #HealthtechInnovation--Imbed Biosciences today announced that Terry Bromley has joined as Chief Executive Officer. With over 30 years of experience in the medical de
Got $250? 2 Healthcare Stocks to Buy and Hold Forever
06:15am, Thursday, 19'th Dec 2024
One of the great things about the stock market is that one doesn't have to be a genius or a multimillionaire to take advantage of its wealth-building power. A person who starts out even with a relativ
These 2 Stocks Just Declared Dividend Raises That Kick In Next Year. Should You Buy?
05:26am, Thursday, 19'th Dec 2024
It isn't easy to find steady and reliable dividend payers in the pharmaceutical industry. The key reason is simple: Drug development is a frequently laborious and expensive process that can swallow va
BioArctic announces global license agreement with Bristol Myers Squibb for BioArctic's PyroGlutamate-amyloid-beta antibody program
01:48am, Thursday, 19'th Dec 2024
STOCKHOLM , Dec. 19, 2024 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announced that it has entered into a global exclusive license agreement with Bristol Myers Squibb (NYSE:
Fangzhou Inc. and Bristol Myers Squibb China Join Forces on a Strategic Alliance to Advance Internet Healthcare
11:40pm, Wednesday, 18'th Dec 2024
SHANGHAI , Dec. 18, 2024 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a pioneer in Internet healthcare solutions, announced a strategic alliance with Bristol Myers Squibb (
Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know
10:00am, Wednesday, 18'th Dec 2024
Bristol Myers (BMY) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Bristol-Myers: Still An Opportunity Yielding Over 4%
09:00am, Wednesday, 18'th Dec 2024
Bristol-Myers Squibb has rallied over 35% in the past 6 months, with shares approaching $60 and a price target of $70. BMY's strong dividend yield exceeds 4%, and strategic acquisitions are expected t
BMY vs. VRTX: Which Stock Is the Better Value Option?
12:45pm, Monday, 16'th Dec 2024
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Bristol Myers Squibb (BMY) or Vertex Pharmaceuticals (VRTX). But which of these two stocks is
Bristol Myers Squibb Announces Dividend Increase
04:17pm, Wednesday, 11'th Dec 2024
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb Announces Dividend Increase.
Bristol Myers Stock Surges 36.5% in Six Months: Time to Buy or Sell?
02:15pm, Tuesday, 10'th Dec 2024
Bristol Myers stock has witnessed a stupendous rally in the past six months. We believe there is more room for growth, and any dip in the share price can be used as a buying opportunity.
Bristol Myers (BMY) Upgraded to Buy: Here's Why
01:01pm, Tuesday, 10'th Dec 2024
Bristol Myers (BMY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Is Bristol Myers Squibb (BMY) a Great Value Stock Right Now?
10:41am, Tuesday, 10'th Dec 2024
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #ASH--Bristol Myers Squibb Highlights Progress of Cell Therapy Portfolio at ASH 2024 with Long-Term Survival Data and Results from Expanding Pipeline.
Bristol Myers A Top Socially Responsible Dividend Stock With 4% Yield
11:19am, Monday, 09'th Dec 2024
Bristol Myers Squibb has been named a Top Socially Responsible Dividend Stock by Dividend Channel, signifying a stock with above-average ''DividendRank'' statistics including a strong 4.0% yield, as w
Buy 3 December Barron's Better Bet 'Safer' Dividend Dogs Of 23
09:40am, Saturday, 07'th Dec 2024
Long-term bond yields continue to rise. But investors looking for income can still find plenty of attractive opportunities with dividend-paying stocks that have healthy yields. “23 stocks pay huge d
Sign In
Buy BMY